Back
Ducommun, Inc. 10K Form
Buy
66
DCO
Ducommun, Inc.
Last Price:
$139.47
Seasonality Move:
5.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2024-05-08 | 10Q | DCO/Ducommun, Inc. Quarterly |
| 2023-11-08 | 10Q | DCO/Ducommun, Inc. Quarterly |
| 2023-08-03 | 10Q | DCO/Ducommun, Inc. Quarterly |
| 2023-05-04 | 10Q | DCO/Ducommun, Inc. Quarterly |
| 2022-11-07 | 10Q | DCO/Ducommun, Inc. Quarterly |
| 2022-08-04 | 10Q | DCO/Ducommun, Inc. Quarterly |
Receive DCO News And Ratings
See the #1 stock for the next 7 days that we like better than DCO
DCO Financial Statistics
Sales & Book Value
| Annual Sales: | $824.7M |
|---|---|
| Cash Flow: | $-78.8M |
| Price / Cash Flow: | 41.41 |
| Annual Sales: | $44.29 |
| Price / Book: | 3.05 |
Profitability
| EPS (TTM): | -2.30220 |
|---|---|
| Net Income (TTM): | $-33.9M |
| Gross Margin: | $221.6M |
| Return on Equity: | -5% |
| Return on Assets: | -2.91% |
Ducommun, Inc. Earnings Forecast
Key Ducommun, Inc. Financial Ratios
-
The Gross Profit Margin over the past 46 years for DCO is 26.87%.
-
The Selling, General & Administrative Expenses for DCO have been equal to 17.51% of Gross Profit Margin.
-
The Research & Development expenses have been 0.00% of Revenue.
-
The Net Earning history of DCO is -4.12% of Total Revenues.
-
Per Share Earnings over the last 46 years have been positive in 17 years.
Ducommun, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Aerospace & Defense |
| Sector: | Industrials |
| Current Symbol: | DCO |
| CUSIP: | 264147 |
| Website: | ducommun.com |
Debt
| Debt-to-Equity Ratio: | 0.52 |
|---|---|
| Current Ratio: | 3.5 |
| Quick Ratio: | 2.35 |
Price-to-Earnings
| Trailing P/E Ratio: | 58.34 |
|---|---|
| Forward P/E Ratio: | 25.69 |
DCO Technical Analysis vs Fundamental Analysis
Buy
66
Ducommun, Inc. (DCO)
is a Buy
Is Ducommun, Inc. a Buy or a Sell?
-
Ducommun, Inc. stock is rated a BuyThe current Ducommun, Inc. [DCO] share price is $135.11. The Score for DCO is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.